Skip to main content
Premium Trial:

Request an Annual Quote

Dharmacon and UMMS Join for RNAi Obesity and Diabetes Studies

NEW YORK, Jan. 8 (GenomeWeb News) - Dharmacon and the University of Massachusetts Medical School said today they will collaborate in studies of obesity and diabetes using RNA interference.


Dharmacon, based in Lafayette, Colo., will provide UMMS researchers, directed by Michael Czech, with siRNA reagents for the studies. The scientists plan to assess several thousand gene targets over a three-year period.


In return, Dharmacon will obtain access to the study data to assess the effectiveness of its siRNA technologies.


The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more